Sublicense AGREEMENT betweenSublicense Agreement • August 5th, 2020 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledAugust 5th, 2020 Company Industry JurisdictionThis Sublicense Agreement (“Agreement”) is made as of July 30, 2020 (“Effective Date”), by and between Isoprene Pharmaceuticals, Inc., a Delaware corporation (“Isoprene”) and Hoth Therapeutics, Inc., a Nevada corporation (“Licensee”).